Full Press Release Details
Lexicon Appoints Scott Coiante as Chief Financial Officer.
LXRX
Lexicon Appoints Scott Coiante as Chief Financial Officer
Key Takeaway: Lexicon Appoints Scott Coiante as Chief Financial Officer
Price reaction · baseline $0.7385 (2024-12-31 close) · hit after-hours · clean, no other LXRX news in the window
day 0 close
+5.2%
day 1
+6.8%
day 3 · peak
+25.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus